Search Page
Save citations to file
Email citations
On or after July 28, sending email will require My NCBI login.
Learn more about this and other changes coming to the email feature.
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 2 |
2025 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial.
Lancet Infect Dis. 2022 May;22(5):622-635. doi: 10.1016/S1473-3099(21)00751-9. Epub 2021 Dec 23.
Lancet Infect Dis. 2022.
PMID: 34953520
Free PMC article.
Clinical Trial.
Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial.
ACTIV-3–Therapeutics for Inpatients with COVID-19 (TICO) Study Group.
ACTIV-3–Therapeutics for Inpatients with COVID-19 (TICO) Study Group.
Lancet Respir Med. 2022 Oct;10(10):972-984. doi: 10.1016/S2213-2600(22)00215-6. Epub 2022 Jul 8.
Lancet Respir Med. 2022.
PMID: 35817072
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.